Literature DB >> 16955816

Doppler echocardiographic prediction of pulmonary hypertension in West Highland white terriers with chronic pulmonary disease.

Karsten E Schober1, Hanno Baade.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is commonly diagnosed by Doppler echocardiography (DE) of tricuspid regurgitation (TR). However, TR may be absent or difficult to measure. HYPOTHESIS: Doppler-derived systolic time intervals of pulmonary artery (PA) flow may be used to predict PH in dogs. ANIMALS: Seventy-three healthy dogs and 45 West Highland white terriers (WHWT) with interstitial pulmonary disease (IPD).
METHODS: Echocardiographic studies, including determination of right ventricular acceleration time (AT), ejection time (ET), and AT : ET ratio; right ventricular shortening fraction (RV-SF); and TR velocity, were performed. Pulmonary hypertension was defined by TR >3.1 m/s.
RESULTS: In healthy WHWT, AT (median, range) was 73 ms (53 to 104) and AT : ET was 0.40 (0.28 to 0.55). AT : ET was minimally affected by age (R2 = 0.04, 95% confidence interval [CI] 0.01-0.07, P < .001) but not by heart rate, body weight, or RV-SF. In all WHWT with TR, AT and AT : ET were inversely related to calculated systolic PA pressure (R2 = 0.52, 95% CI 0.42-0.62, P < .001 and R2 = 0.36, 95% CI 0.29-0.42, P = .001). Clinical cutoffs to predict systolic PH were defined for AT (58 ms; sensitivity [Se] 88% and specificity [Sp] 80%) and AT : ET (0.31; Se 73% and Sp 87%). CONCLUSION AND CLINICAL IMPORTANCE: PH is common in WHWT with IPD. Analysis of right ventricular AT and AT : ET may be predictive of PH and should be particularly useful if TR is absent.

Entities:  

Mesh:

Year:  2006        PMID: 16955816     DOI: 10.1892/0891-6640(2006)20[912:depoph]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  25 in total

1.  Doppler echocardiographic evidence of pulmonary hypertension in dogs: a retrospective clinical investigation.

Authors:  P Paradies; P P Spagnolo; M E Amato; D Pulpito; M Sasanelli
Journal:  Vet Res Commun       Date:  2014-01-11       Impact factor: 2.459

2.  Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension.

Authors:  Lydia C Soydan; Heidi B Kellihan; Melissa L Bates; Rebecca L Stepien; Daniel W Consigny; Alessandro Bellofiore; Christopher J Francois; Naomi C Chesler
Journal:  J Vet Cardiol       Date:  2015-01-16       Impact factor: 1.701

3.  Adjunct ambrisentan therapy had clinical benefits in 5 dogs with sildenafil-refractory pulmonary hypertension.

Authors:  Seijirow Goya; Tomohiko Yoshida; Shigeharu Sennba; Tsuyoshi Uchide; Ryou Tanaka
Journal:  Can Vet J       Date:  2022-05       Impact factor: 1.075

4.  Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension.

Authors:  Sheeraz Habash; Kai Thorsten Laser; Julia Moosmann; Roland Reif; Werner Adler; Martin Glöckler; Deniz Kececioglu; Sven Dittrich
Journal:  Int J Cardiovasc Imaging       Date:  2019-01-28       Impact factor: 2.357

5.  Pre- and post-operative cardiac evaluation of dogs undergoing lobectomy and pneumonectomy.

Authors:  Meriç Kocatürk; Hakan Salci; Zeki Yilmaz; A Sami Bayram; Jørgen Koch
Journal:  J Vet Sci       Date:  2010-09       Impact factor: 1.672

6.  Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  Shoma Mikawa; Yuichi Miyagawa; Noriko Toda; Yoshinori Tominaga; Naoyuki Takemura
Journal:  J Vet Med Sci       Date:  2014-10-16       Impact factor: 1.267

7.  Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis.

Authors:  L I O Lilja-Maula; H P Laurila; P Syrjä; A K Lappalainen; E Krafft; C Clercx; M M Rajamäki
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

8.  Holter monitoring of small breed dogs with advanced myxomatous mitral valve disease with and without a history of syncope.

Authors:  C E Rasmussen; T Falk; A Domanjko Petrič; M Schaldemose; N E Zois; S G Moesgaard; B Ablad; H Y Nilsen; I Ljungvall; K Höglund; J Häggström; H D Pedersen; J M Bland; L H Olsen
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

9.  Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.

Authors:  A Tidholm; K Höglund; J Häggström; I Ljungvall
Journal:  J Vet Intern Med       Date:  2015-09-14       Impact factor: 3.333

10.  Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.

Authors:  P R Fox; M A Oyama; M J Hezzell; J E Rush; T P Nguyenba; T C DeFrancesco; L B Lehmkuhl; H B Kellihan; B Bulmer; S G Gordon; S M Cunningham; J MacGregor; R L Stepien; B Lefbom; D Adin; K Lamb
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.